EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Timely Diagnosis of Cobalamin C Disease via Rapid Genome Sequencing in a Neonate With Severe Prenatally Detected Biventricular Dysfunction

Yutaka Furuta iD, Samantha N Walkin, Scott K Ward iD, Rory J Tinker iD, Rizwan Hamid, John A Phillips, Rachel E Harris iD, Thomas A Cassini iD

Case Reports in Critical Care · 2026-01 · 2026 (1)

DOI: 10.1155/crcc/2778022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Critical Care, online erschienen am 02.08.2026. Verfasst von Yutaka Furuta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA, vanderb…. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cobalamin C (Cbl‐C) disease, the most common inborn error of cobalamin metabolism caused by biallelic pathogenic MMACHC variants, leads to multisystem involvement from methylmalonic acid and homocysteine accumulation. When diagnosed early, it is treatable. Rapid genome sequencing (GS) is becoming increasingly accessible and enables timely diagnosis and prompt treatment. We report a neonate who had severely decreased prenatal and postnatal biventricular function requiring inotropic support. Given the critically ill condition and unclear etiology, rapid GS was obtained and revealed homozygous pathogenic MMACHC variants, confirming a diagnosis of Cbl‐C disease. This prompted the early initiation of treatment with high‐dose hydroxocobalamin, betaine, levocarnitine, and folic acid. His cardiac function gradually improved, and he was discharged at 28 days of life. Critical care providers should suspect treatable inherited metabolic disorders in patients with unexplained presentations and recognize rapid GS as a powerful tool for early identification and treatment in critically ill patients.

Schlagwörter

Stichwörter der Autor:innen

biventricular dysfunctioncardiomyopathycobalamin C diseaseintensive carerapid genome sequencing

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA, vanderbilt.edu.
  • Department of Medical Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, New York, USA, mountsinai.org.
  • Department of Pediatrics, Division of Pediatric Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA, vanderbilt.edu.

ORCID-Profile: Yutaka Furuta, Scott K Ward, Rory J Tinker, Rachel E Harris, Thomas A Cassini

Zitieren

APA

Furuta, Y., Walkin, S. N., Ward, S. K., Tinker, R. J., Hamid, R., Phillips, J. A., Harris, R. E., & Cassini, T. A. (2026). Timely Diagnosis of Cobalamin C Disease via Rapid Genome Sequencing in a Neonate With Severe Prenatally Detected Biventricular Dysfunction. Case Reports in Critical Care, 2026(1). https://doi.org/10.1155/crcc/2778022

Vancouver

Furuta Y, Walkin SN, Ward SK, Tinker RJ, Hamid R, Phillips JA, et al. Timely Diagnosis of Cobalamin C Disease via Rapid Genome Sequencing in a Neonate With Severe Prenatally Detected Biventricular Dysfunction. Case Reports in Critical Care. 2026;2026(1). doi:10.1155/crcc/2778022

BibTeX
@article{Furuta2026,
  author = {Furuta, Yutaka and Walkin, Samantha N and Ward, Scott K and Tinker, Rory J and Hamid, Rizwan and Phillips, John A and Harris, Rachel E and Cassini, Thomas A},
  title = {Timely Diagnosis of Cobalamin C Disease via Rapid Genome Sequencing in a Neonate With Severe Prenatally Detected Biventricular Dysfunction},
  journal = {Case Reports in Critical Care},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crcc/2778022}
}
Kostenlos starten →